WATSON 453

Pill imprint WATSON 453 has been identified as Guanfacine hydrochloride 2 mg.

Guanfacine is used in the treatment of adhd; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy.

Guanfacine 2 mg is not subject to the Controlled Substances Act.
See also related documents.

Guanfacine hydrochloride Images

Imprint:
WATSON 453
Strength:
2 mg
Color:
Orange
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Inactive Ingredients:
lactose anhydrous
D&C Yellow No. 10
FD&C Red No. 40
povidone
stearic acid
microcrystalline cellulose
aluminum oxide
Drug Class:
Antiadrenergic agents, centrally acting
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0453

View Drug DetailsPrint Page

Guanfacine hydrochloride 2 mg WATSON 453  Front
Guanfacine hydrochloride 2 mg WATSON 453  Back
Guanfacine hydrochloride 2 mg WATSON 453
Advertisement

Guanfacine Hydrochloride is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web1)